Cohort life expectancy is the average number of years a group of people born in the same year will actually live, tracked from birth through death. Unlike the life expectancy figure you typically see in news headlines, which is a snapshot of one year’s death rates applied to all ages, cohort life expectancy follows a real generation through time and accounts for improvements in medicine, public health, and living conditions that haven’t happened yet. For boys born in the UK in 2023, cohort life expectancy is 86.7 years. For girls, it’s 90.0 years. Those numbers are significantly higher than the period life expectancy figures you’ll see reported for the same year, and the difference between the two measures matters more than most people realize.
How It Differs From Period Life Expectancy
The life expectancy number reported in most news stories is “period” life expectancy. It takes everyone who died in a single calendar year, calculates the death rate at every age, and asks: if a baby born today faced those exact death rates for their entire life, how long would they live? The problem is that no one actually faces the same death rates for 80 or 90 years. Medical care improves. Diseases get treated more effectively. Sanitation, nutrition, and workplace safety all tend to get better over time. Period life expectancy ignores all of that. It freezes mortality conditions in place as if nothing will ever change.
Cohort life expectancy works differently. It tracks a group of people born in a specific year, sometimes called a “birth cohort,” and uses the actual death rates they experienced at each age. For a 65-year-old born in 1960, it uses the real mortality data from when that cohort was 20, 30, 40, and so on. For ages the cohort hasn’t reached yet, it uses projected mortality rates that account for expected improvements. So cohort life expectancy at age 65 in 2020 would use the mortality rate for 65-year-olds in 2020, for 66-year-olds in 2021, for 67-year-olds in 2022, and so on into the future.
This is why cohort life expectancy is almost always higher than period life expectancy. It bakes in the reasonable assumption that survival will keep improving, even modestly, over a person’s lifetime. Period life expectancy is a useful summary of current conditions, but cohort life expectancy comes closer to answering the question most people actually care about: how long can I expect to live?
What the Numbers Look Like Across Generations
The gains in cohort life expectancy over the past century have been dramatic. According to Social Security Administration data, a boy born in 1900 had a cohort life expectancy of 51.5 years. By 2001, that figure had climbed to 80.1 years, a gain of 28.6 years. For girls, the jump went from 58.3 years in 1900 to 84.3 years in 2001, a gain of 26.0 years.
Those gains weren’t evenly distributed. A JAMA Network Open study examining cohort life expectancy across all U.S. states found enormous geographic variation. Washington, D.C. saw the most dramatic change: females born there in 1900 had a cohort life expectancy of 63.9 years, compared to 93.0 years for the 2000 cohort. Males jumped from 48.7 to 86.5 years. Some states in the West and Northeast saw increases greater than 30 years between the 1900 and 2000 cohorts. But parts of the South saw female cohort life expectancy increase by less than 2 years over that same century, and male life expectancy in some Southern states barely budged after 1950.
Looking further ahead, UK projections estimate that boys born in 2047 will have a cohort life expectancy of 89.3 years and girls 92.2 years. That represents a gain of roughly 2.5 years over just 24 years, a pace that reflects the widely observed slowdown in life expectancy improvements compared to the rapid gains of the mid-20th century.
Why Some Cohorts Live Longer Than Others
The early 20th century gains were driven largely by reductions in infant and childhood mortality. Clean water, vaccines, antibiotics, and better nutrition meant far more children survived to adulthood. As those victories were won, the gains shifted to older ages, driven by improvements in treating heart disease, cancer screening, and managing chronic conditions.
But medical advances aren’t the only factor. Research from the American Journal of Epidemiology found that the modest gains in life expectancy across recent U.S. birth cohorts resulted almost entirely from shifts in educational attainment. More people completing higher education meant better employment, higher incomes, safer working conditions, greater health literacy, stronger social networks, and a greater sense of personal control over health decisions. These factors compound across a lifetime. The study found that rising education levels not only increased total life expectancy but compressed the period of disability at the end of life, meaning people lived both longer and healthier. Growing inequality between educational groups, however, meant those benefits were not shared equally.
Why It Matters for Pensions and Retirement
Cohort life expectancy has enormous practical consequences for anyone managing money over long time horizons. Pension funds, insurance companies, and government retirement programs all need to know how long retirees will actually live, not just how long current death rates suggest they might.
Using period life expectancy for pension planning systematically underestimates how long people will collect benefits. Research published in the Journal of Pension Economics and Finance found that relying on the lower period figure can make a pension scheme look financially solvent when it isn’t. The assets stay the same, but the real liabilities (years of payments owed to retirees) are larger than the period-based calculation suggests. This applies to both government-funded programs and private pension funds. For individuals, the same logic applies to retirement savings: if you plan based on period life expectancy, you may underestimate how many years your money needs to last.
The Uncertainty Built Into the Estimate
For anyone born before roughly 1940, cohort life expectancy can be calculated almost entirely from observed data, since most members of those cohorts have already died. For younger cohorts, the number depends increasingly on projections. A cohort life expectancy figure for someone born in 2023 is really a best estimate built on assumptions about how quickly mortality will continue to improve over the next 90 years.
Those assumptions carry real uncertainty. Pandemics, changes in obesity rates, the opioid crisis, climate effects, and breakthroughs in treating age-related diseases could all push the actual numbers higher or lower than current projections. Recent research in PNAS has identified signs that life expectancy gains are decelerating in many high-income countries, which could mean current projections are slightly optimistic. On the other hand, period-based measures that reflect temporary shocks (like elevated death rates during COVID-19) can paint an overly pessimistic picture. As researchers have noted, only a cohort perspective can definitively assess how long a generation actually lives. Period measures may suggest adverse mortality trends that don’t hold up when you follow real people through real time.
This is the core tension with cohort life expectancy: it is the more accurate concept, but for living generations, it can never be fully known until the last member of the cohort has died. Every figure you see for people born after about 1950 contains some element of forecasting. The further into the future those forecasts extend, the wider the range of possible outcomes.